Copan Italia SpA:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Copan Italia SpA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10300
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Copan Italia SpA (Copan Italia) is a medical equipment provider that offers lab consumables and diagnostic products. The company’s products include clinical products, lab automation products, and genetics, forensics, and lab consumable products, among others. Its lab automation products allow microbiology laboratory to perform significant portions of routine activities in automated applications and microbiology fields, among others. Copan Italia also provides bacteriology laboratory automation and offers supply of collection and transport systems, among others. The company provides technical support in pack inserts and certifications. It has its operations in China, Italy, and the US. Copan Italia is headquartered in Brescia, Italy.

Copan Italia SpA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Copan Italia SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Copan Italia SpA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Copan Italia SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Copan Italia SpA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Copan Italia SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Copan Italia SpA, Medical Equipment, Deal Details 10
Partnerships 10
Copan Italia Forms Joint Venture with Shinji Matsuura 10
BioMerieux Enters into Distribution Agreement with Copan 11
BioMerieux Enters into Co-Development Agreement with Copan Italia 12
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 13
Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 14
Asset Transactions 15
Hamilton Regional Labs To Acquire WASPLab From Copan Diagnostics 15
Copan Italia SpA – Key Competitors 16
Copan Italia SpA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Legal and Regulatory 18
Jun 04, 2018: COPAN Announces Lawsuit for Patent Infringement and Unfair Competition Against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC 18
Product News 19
Sep 10, 2018: Summary Judgment in favor of COPAN on Puritan Medical Products claim for bad faith assertion of patent infringement 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Copan Italia SpA, Medical Equipment, Key Facts 2
Copan Italia SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Copan Italia SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Copan Italia SpA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Copan Italia SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Copan Italia SpA, Deals By Market, 2012 to YTD 2018 8
Copan Italia SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Copan Italia Forms Joint Venture with Shinji Matsuura 10
BioMerieux Enters into Distribution Agreement with Copan 11
BioMerieux Enters into Co-Development Agreement with Copan Italia 12
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 13
Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 14
Hamilton Regional Labs To Acquire WASPLab From Copan Diagnostics 15
Copan Italia SpA, Key Competitors 16
Copan Italia SpA, Subsidiaries 17

List of Figures
Copan Italia SpA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Copan Italia SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Copan Italia SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Copan Italia SpA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Copan Italia SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Copan Italia SpA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Copan Italia SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Copan Italia SpA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Copan Italia SpA:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Daigas Group:企業の戦略・SWOT・財務分析
    Daigas Group - Strategy, SWOT and Corporate Finance Report Summary Daigas Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Brenntag AG:企業の戦略・SWOT・財務情報
    Brenntag AG - Strategy, SWOT and Corporate Finance Report Summary Brenntag AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • John Wood Group Plc (WG.):石油・ガス:M&Aディール及び事業提携情報
    Summary John Wood Group Plc (Wood) is a provider of project, engineering and technical services. The company offers comprehensive solutions that improve the performance of customers' industrial assets across the asset life cycle. Its services span from concept to decommissioning and include asset so …
  • Proteostasis Therapeutics Inc (PTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteostasis Therapeutics Inc (Proteostasis) is a developer of therapies that discovers and develops therapeutics for the treatment of diseases related to defects in protein folding, trafficking and clearance. The company’s portfolio spans drug candidates for cystic fibrosis, neurodegenerati …
  • Digna Biotech SL-製薬・医療分野:企業M&A・提携分析
    Summary Digna Biotech SL (Digna) is a biotechnology company that specializes in the development and commercialization of robust clinical therapeutic candidates. The company’s pipeline portfolio includes cutaneous manifestation of scleroderma, clinical indications for kidney transplant and liver surg …
  • Unique Catering & Management Services Ltd:企業の戦略・SWOT・財務情報
    Unique Catering & Management Services Ltd - Strategy, SWOT and Corporate Finance Report Summary Unique Catering & Management Services Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Promedior Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Promedior Inc (Promedior) is a clinical-stage biotechnology company that develops medicines for the treatment of fibrotic disorders. The company’s pipeline products include PRM-151 and PRM-167. PRM-151 is used in the treatment of rare systemic fibrotic diseases such as myelofibrosis and idio …
  • Neuwave Medical Inc-医療機器分野:企業M&A・提携分析
    Summary NeuWave Medical Inc (NeuWave), a subsidiary of Ethicon US LLC is a medical device company that develops and commercializes energy-based minimally invasive medical devices. Its flagship product, Certus 140 microwave ablation (coagulation) system, is a minimally invasive soft tissue ablation s …
  • Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析
    Summary Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude …
  • Magma Fincorp Limited:企業のM&A・事業提携・投資動向
    Magma Fincorp Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Magma Fincorp Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Eco (Atlantic) Oil & Gas Ltd (EOG):企業の財務・戦略的SWOT分析
    Summary Eco (Atlantic) Oil & Gas Ltd (Eco) is an oil and gas exploration and development company. The company’s business activities include acquisition, identification, and development of upstream petroleum projects across Africa. The company's projects include cooper license-PEL 030, Sharon license …
  • Checkpoint Systems, Inc.:企業の戦略・SWOT・財務情報
    Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • SMART Medical Systems Ltd-医療機器分野:企業M&A・提携分析
    Summary Smart Medical Systems Ltd (Smart) is a medical device company that develops and manufactures medical equipment in the field of gastroenterology and GI endoscopy. The company offers products such as inflation systems, platform, naviaid ABC, G-eye, naviaid AB, future naviaid products, controll …
  • KPMG International Coop:企業の戦略的SWOT分析
    KPMG International Coop - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Yamana Gold Inc.:企業の戦略・SWOT・財務情報
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • National Grid Plc:企業の発電所・SWOT分析2018
    National Grid Plc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Numab Innovation AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Numab Innovation AG (Numab) is a developer of novel therapeutics for the treatment of severe diseases. The company’s pipeline products include ND007, ND009, ND016, ND017, ND023, ND026, and ND021. Its ND007 is a bispecific antibody fragment which is being evaluated for the treatment of autoim …
  • SELEX Galileo Inc.:企業の戦略・SWOT・財務情報
    SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report Summary SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cosan S.A. Industria e Comercio (CSAN3):電力:M&Aディール及び事業提携情報
    Summary Cosan S.A. Industria e Comercio (Cosan), a subsidiary of Cosan Limited, is an integrated bioenergy company. It invests in diversified industries including agribusiness, fuel and natural gas distribution, and lubricants. The company distributes lubricants, fuel oil, and piped natural gas; and …
  • Composites Technology Research Malaysia Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆